ahlam1399
07-01-2016, 12:41 PM
UPDATE 1-AstraZeneca sells two dermatology drug rights to LEO Pharma
July 1 (Reuters) - British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stagedrug to treat atopic dermatitis to privately-held LEO Pharma.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=v_FFP_yerL4:uxGOPOo0Ous:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=v_FFP_yerL4:uxGOPOo0Ous:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/v_FFP_yerL4
July 1 (Reuters) - British drugmaker AstraZeneca Plc said it sold the rights to develop an experimental mid-stagedrug to treat atopic dermatitis to privately-held LEO Pharma.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=v_FFP_yerL4:uxGOPOo0Ous:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=v_FFP_yerL4:uxGOPOo0Ous:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=v_FFP_yerL4:uxGOPOo0Ous:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/v_FFP_yerL4